Catherine E. Peishoff

4.5k total citations · 3 hit papers
30 papers, 3.3k citations indexed

About

Catherine E. Peishoff is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Catherine E. Peishoff has authored 30 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Catherine E. Peishoff's work include Computational Drug Discovery Methods (10 papers), Chemical Synthesis and Analysis (6 papers) and Protein Structure and Dynamics (6 papers). Catherine E. Peishoff is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Chemical Synthesis and Analysis (6 papers) and Protein Structure and Dynamics (6 papers). Catherine E. Peishoff collaborates with scholars based in United States, United Kingdom and Switzerland. Catherine E. Peishoff's co-authors include Brian K. Shoichet, Andrew R. Leach, Millard H. Lambert, C. Webster Andrews, Mika Lindvall, Martha S. Head, Brian Clarke, Gregory L. Warren, James M. Woolven and Giovanna Tedesco and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Catherine E. Peishoff

29 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Critical Assessment of Docking Programs and Scoring Functions

2005 1.3k citations Millard H. Lambert, Catherine E. Peishoff et al. Journal of Medicinal Chemistry profile →
Thousands of chemical starting points for antimalarial lead identification

2010 705 citations Francisco‐Javier Gamo, Laura M. Sanz et al. Nature profile →
Prediction of Protein−Ligand Interactions. Docking and Scoring: Successes and Gaps

2006 506 citations Catherine E. Peishoff et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine E. Peishoff United States	16	2.1k	1.6k	608	477	365	30	3.3k
Maria A. Miteva France	37	3.2k 1.5×	2.0k 1.2×	728 1.2×	158 0.3×	442 1.2×	129	5.2k
Nadine Homeyer Germany	11	3.3k 1.6×	1.1k 0.7×	671 1.1×	142 0.3×	487 1.3×	18	4.9k
Herman van Vlijmen Belgium	38	3.1k 1.5×	1.3k 0.8×	406 0.7×	92 0.2×	784 2.1×	98	4.3k
Jin Huang China	34	2.5k 1.2×	1.2k 0.8×	637 1.0×	203 0.4×	365 1.0×	164	4.4k
Jeffrey R. Huth United States	26	2.2k 1.1×	637 0.4×	548 0.9×	80 0.2×	254 0.7×	40	3.3k
A. Geoffrey Skillman United States	17	2.5k 1.2×	1.9k 1.2×	693 1.1×	180 0.4×	614 1.7×	26	3.8k
Michael J. Hartshorn United Kingdom	17	3.7k 1.8×	2.1k 1.3×	910 1.5×	143 0.3×	697 1.9×	21	5.5k
Darren V. S. Green United Kingdom	28	1.8k 0.9×	1.7k 1.1×	906 1.5×	510 1.1×	400 1.1×	58	3.8k
Helge Weissig United States	13	2.9k 1.4×	565 0.4×	451 0.7×	82 0.2×	475 1.3×	23	3.9k
David L. Pompliano United States	23	3.2k 1.5×	640 0.4×	930 1.5×	193 0.4×	376 1.0×	36	5.1k

Countries citing papers authored by Catherine E. Peishoff

Since Specialization

Citations

This map shows the geographic impact of Catherine E. Peishoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Peishoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Peishoff more than expected).

Fields of papers citing papers by Catherine E. Peishoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Peishoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Peishoff. The network helps show where Catherine E. Peishoff may publish in the future.

Co-authorship network of co-authors of Catherine E. Peishoff

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Peishoff. A scholar is included among the top collaborators of Catherine E. Peishoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Peishoff. Catherine E. Peishoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sherborne, Bradley, Veerabahu Shanmugasundaram, Alan C. Cheng, et al.. (2016). Collaborating to improve the use of free-energy and other quantitative methods in drug discovery. Journal of Computer-Aided Molecular Design. 30(12). 1139–1141. 38 indexed citations

Carlson, Heather A., Richard D. Smith, Kelly L. Damm‐Ganamet, et al.. (2016). CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma. Journal of Chemical Information and Modeling. 56(6). 1063–1077. 82 indexed citations

Gamo, Francisco‐Javier, Laura M. Sanz, Jaume Vidal, et al.. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature. 465(7296). 305–310. 705 indexed citations breakdown →

Elliott, John D., Eliot H. Ohlstein, Catherine E. Peishoff, Harma Ellens, & M. Amparo Lago. (2006). Endothelin Receptor Antagonists. Kluwer Academic Publishers eBooks. 11. 113–129. 5 indexed citations

Dhanak, Dashyant, George Burton, Michael G. Darcy, et al.. (2000). Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorganic & Medicinal Chemistry Letters. 10(20). 2279–2282. 10 indexed citations

Thompson, Scott K., Daniel F. Veber, Anthony J. Jurewicz, et al.. (1996). Design and evaluation of small peptides mapping the exposed surface of IL‐8. International journal of peptide & protein research. 47(3). 214–218. 5 indexed citations

Ku, Thomas W., William H. Miller, William E. Bondinell, et al.. (1995). Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophore. Journal of Medicinal Chemistry. 38(1). 9–12. 20 indexed citations

Hill, David T., Gerald R. Girard, Joseph Weinstock, et al.. (1995). and -N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 5(1). 19–24. 5 indexed citations

Peishoff, Catherine E., Robert W. Janes, & B.A. Wallace. (1995). Comparison of the structures of the endothelin A receptor antagonists BQ123 andN‐methyl leucine BQ123 with the crystal structure of the C‐terminal tail of endothelin‐1. FEBS Letters. 374(3). 379–383. 9 indexed citations

10.

Bean, John W., Catherine E. Peishoff, & Kenneth D. Kopple. (1994). Conformations of cyclic pentapeptide endothelin receptor antagonists. International journal of peptide & protein research. 44(3). 223–232. 12 indexed citations

11.

Lee, Jonathan A., Catherine E. Peishoff, M. Amparo Lago, et al.. (1994). Lysine 182 of Endothelin B Receptor Modulates Agonist Selectivity and Antagonist Affinity: Evidence for the Overlap of Peptide and Non-peptide Ligand Binding Sites. Biochemistry. 33(48). 14543–14549. 22 indexed citations

12.

Kopple, Kenneth D., et al.. (1993). Conformational mobility in cyclic oligopeptides. Biopolymers. 33(7). 1093–1099. 14 indexed citations

13.

Samanen, James M., Catherine E. Peishoff, Richard M. Keenan, & Joseph Weinstock. (1993). Refinement of a molecular model of angiotensin II (AII) employed in the discovery of potent nonpeptide antagonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 909–914. 22 indexed citations

14.

Peishoff, Catherine E., Fadia E. Ali, John W. Bean, et al.. (1992). Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides. Journal of Medicinal Chemistry. 35(21). 3962–3969. 78 indexed citations

15.

Callahan, James F., John W. Bean, Joelle L. Burgess, et al.. (1992). Design and synthesis of a C7 mimetic for the predicted .gamma.-turn conformation found in several constrained RGD antagonists. Journal of Medicinal Chemistry. 35(21). 3970–3972. 56 indexed citations

16.

Peishoff, Catherine E. & Jonathan S. Dixon. (1992). Improvements to the distance geometry algorithm for conformational sampling of cyclic structures. Journal of Computational Chemistry. 13(5). 565–569. 24 indexed citations

17.

Kopple, Kenneth D., et al.. (1992). Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: solution and crystal studies. Journal of the American Chemical Society. 114(24). 9615–9623. 66 indexed citations

18.

Louis-Flamberg, Pearl, Catherine E. Peishoff, Deborah Bryan, et al.. (1990). Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochemistry. 29(17). 4115–4120. 11 indexed citations

19.

Peishoff, Catherine E., Jonathan S. Dixon, & Kenneth D. Kopple. (1990). Application of the distance geometry algorithm to cyclic oligopeptide conformation searches. Biopolymers. 30(1-2). 45–56. 12 indexed citations

20.

Peishoff, Catherine E. & William L. Jorgensen. (1983). Computer-assisted mechanistic evaluation of organic reactions. 4. Organosilicon chemistry. The Journal of Organic Chemistry. 48(12). 1970–1979. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact